Skip to main content

Adam Seegmiller Archives

Seegmiller named to new pathology, laboratory medicine leadership posts

Feb. 18, 2021—Adam Seegmiller, MD, PhD, has been named the inaugural vice chair for Clinical Affairs in the Department of Pathology, Microbiology and Immunology as well as executive medical director of the newly formed Pathology and Laboratory Medicine — Clinical Service Center.

Read more


Price’s old laboratory recipe book proves to be invaluable

Apr. 30, 2020—Howard Price has a decades-old green notebook he keeps in his office at Vanderbilt University Medical Center, and when a shortage of a critical laboratory supply nearly brought testing for SARS-CoV-2, the virus that causes COVID-19, to a halt at the Medical Center, the notebook’s contents quickly became invaluable.

Read more


Collaboration key to rapid expansion of lab test capacity

Apr. 23, 2020—The rapid ramping up of SARS-CoV-2 testing at VUMC reflects the dedication of the professionals who work in the Clinical Laboratory and also their collaboration with colleagues in research laboratories throughout VUMC.

Read more


Diagnostic testing for genetic disorders now available on site

Mar. 12, 2020—Vanderbilt University Medical Center has opened a Clinical Genomics Laboratory to provide diagnostic testing for genetic disorders.

Read more


VUMC Diagnostic Laboratories expand, improve services

Jul. 19, 2018—Vanderbilt University Medical Center’s Diagnostic Laboratories continue to expand in-house services in order to more efficiently diagnose and treat patients. A recent survey indicates clinicians’ overall satisfaction with the efforts.

Read more


New labeling system speeds clinical lab turnaround times

Apr. 19, 2018—Much of everyday clinical decision-making is informed by lab tests performed rapidly on automated instrumentation — basic metabolic panels, complete blood counts, all the lab orders for which clinicians expect quick results.

Read more


Reversing lipid woes in cystic fibrosis

Mar. 3, 2012—Abnormal levels of fatty acids in the blood and tissues of patients with cystic fibrosis may be reversed by supplementation with the fatty acids DHA and EPA.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more